Medicare Enrolled

Dr. Raed Alalawi, M.D.

Critical Care Medicine · Lubbock, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Consulting-driven
3601 4TH ST, Lubbock, TX 79430
8067433150
In practice since 2007 (19 years)
NPI: 1366566176 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alalawi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alalawi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Alalawi

Dr. Raed Alalawi is a critical care medicine in Lubbock, TX, with 19 years in practice. Based on federal Medicare data, Dr. Alalawi performed 487 Medicare services across 332 unique beneficiaries.

Between the years covered by Open Payments, Dr. Alalawi received a total of $43,558 from 41 pharmaceutical and/or device companies across 266 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Alalawi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 487 Medicare services$ $43,558 industry payments

Medicare Practice Summary

Medicare Utilization ↗
487
Medicare services
Bottom 49% in TX for critical care medicine
332
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~26 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity185$93$266
Office visit, established patient (30-39 min)60$74$150
Office visit, established patient (20-29 min)50$43$73
Telephone medical discussion with physician, 21-30 minutes38$70$100
Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound23$51$176
New patient office visit (45-59 min)21$94$277
Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes16$177$639
New patient office visit (30-44 min)16$65$150
Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope15$90$485
Irrigation and suction of lung airways to obtain cells using an endoscope14$27$350
Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes14$158$576
Hospital follow-up visit, moderate complexity13$62$185
Computer-assisted image-guided navigation of lung airways using an endoscope11$74$251
Biopsy of lobe of lung using an endoscope, 1 lobe11$57$457
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$43,558
Total received (2018-2024)
Avg $6,223/year across 7 years
Top 7% in TX for critical care medicine
41
Companies
266
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$18,035 (41.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13,070 (30.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,452 (28.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,075
2023
$11,716
2022
$7,540
2021
$1,985
2020
$1,427
2019
$12,947
2018
$5,867

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Pulmonx Corporation
$17,483
Intuitive Surgical, Inc.
$6,101
Cook Incorporated
$5,400
GlaxoSmithKline, LLC.
$2,837
CSA Medical, Inc
$2,644
Pinnacle Biologics, Inc
$1,892
Veran Medical Technologies, Inc.
$1,397
INTUITIVE SURGICAL, INC.
$1,119
Boston Scientific Corporation
$710
Inari Medical, Inc.
$555
United Therapeutics Corporation
$548
Olympus America Inc.
$483
Grifols USA, LLC
$459
Ethicon Inc.
$444
Actelion Pharmaceuticals US, Inc.
$178
Philips Electronics North America Corporation
$158
Janssen Pharmaceuticals, Inc
$106
Galvanize Therapeutics, Inc
$98
AstraZeneca Pharmaceuticals LP
$97
Cook Medical LLC
$91
Allergan Inc.
$86
Electromed, Inc.
$73
Genentech USA, Inc.
$72
Boehringer Ingelheim Pharmaceuticals, Inc.
$67
Astellas Pharma US Inc
$64
Sandoz Inc.
$56
Insmed, Inc.
$54
Regeneron Healthcare Solutions, Inc.
$31
ABBVIE INC.
$28
Vapotherm Inc
$28
Shire North American Group Inc
$28
Allergan, Inc.
$25
Siemens Medical Solutions USA, Inc.
$22
Sunovion Pharmaceuticals Inc.
$20
Covidien LP
$17
Paratek Pharmaceuticals, Inc.
$16
Haemonetics Corporation
$16
Advanced Respiratory, Inc
$15
La Jolla Pharmaceutical Company
$15
Mylan Specialty L.P.
$13
Bayer HealthCare Pharmaceuticals Inc.
$11
Top 3 companies account for 66.5% of total payments
Associated products mentioned in payments ›
120V · 60Hz · ALAIR · ALIYA SYSTEM · AMBISOME · ANORO · AVYCAZ · Arikayce · Artis zee · BLUE RHINO · BREZTRI · Betaseron · CHARTIS CATHETER · CRESEMBA · Cresemba · DUPIXENT · Da Vinci Surgical System · EVIS EXERA II ULTRASONIC BRONCHOFIBERVIDEOSCOPE · EVIS EXERA III BRONCHOVIDEOSCOPE · EXPECT · Esbriet · FASENRA · FLOWTRIEVER CATHETER · GENERAL BRONCHIAL THERMOPLASTY · GENERAL PULMONARY · GIAPREZA · GLASSIA · ION · LONHALA MAGNAIR · MONARCH · Monarch · Monarch Platform · NUCALA · NUZYRA · OPSUMIT · ORENITRAM · Olympus · Photofrin · Precision Flow · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · REMODULIN · S · S&RC Und · SINGLE USE SUCTION VALVE (Sterile) · SMARTVEST · SPiN Thoracic Navigation System · STIOLTO RESPIMAT · SYMBICORT · Spin · Spiration Valve System · TEG · TREPROSTINIL · TYVASO · The Vest System Model 105 Home Care · ULTRAFLEX · Ventilator · XARELTO · Yupelri · ZEPHYR DELIVERY CATHETER · ZEPHYR ENDOBRONCHIAL VALVE · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (41%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 7% for critical care medicine in TX.

Equivalent to $8,944 per 100 Medicare services performed
Looking for a critical care medicine in Lubbock?
Compare critical care medicines in the Lubbock area by procedure volume, costs, and industry payment transparency.
Browse critical care medicines nearby

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Alalawi is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 7%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Alalawi experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Alalawi performed 185 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alalawi receive payments from pharmaceutical companies?
Yes. Dr. Alalawi received a total of $43,558 from 41 companies across 266 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alalawi's costs compare to other critical care medicines in Lubbock?
Dr. Alalawi's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alalawi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →